136 related articles for article (PubMed ID: 18799898)
21. Pharmacokinetics and pharmacogenomics in gastric cancer chemotherapy.
Nishiyama M; Eguchi H
Adv Drug Deliv Rev; 2009 May; 61(5):402-7. PubMed ID: 19133303
[TBL] [Abstract][Full Text] [Related]
22. Biweekly oxaliplatin, fluorouracil and leucovorin versus cisplatin, fluorouracil and leucovorin in patients with advanced gastric cancer.
Popov I; Radosevic-Jelic L; Jezdic S; Milovic M; Borojevic N; Stojanovic S; Stankovic V; Josifovski T; Kezic I
J BUON; 2008; 13(4):505-11. PubMed ID: 19145671
[TBL] [Abstract][Full Text] [Related]
23. [The current situation and subjects of the intraperitoneal chemotherapy for peritoneal dissemination in gastric cancer].
Hirono Y; Fujimoto D; Nagano H; Murakami M; Katayama K; Yamaguchi A
Gan To Kagaku Ryoho; 2008 Jun; 35(6):891-5. PubMed ID: 18633215
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of the gastric cancer treatment guidelines of the Japanese Gastric Cancer Association].
Sano T
Gan To Kagaku Ryoho; 2010 Apr; 37(4):582-6. PubMed ID: 20414011
[TBL] [Abstract][Full Text] [Related]
25. [Clinical trial of non-specific immunotherapy using Lentinan in advanced or recurrent gastric cancer].
Yoshino S; Oka M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2239-43. PubMed ID: 19106583
[TBL] [Abstract][Full Text] [Related]
26. Disparities in gastric cancer chemotherapy between the East and West.
Ohtsu A; Yoshida S; Saijo N
J Clin Oncol; 2006 May; 24(14):2188-96. PubMed ID: 16682738
[TBL] [Abstract][Full Text] [Related]
27. [The efficacy of S-1 monotherapy as a 2nd/3rd-line therapy for unresectable recurrent colon cancer: Kanagawa conference of clinical oncology (KCCO)].
Yokoyama T; Tokuhara H; Egawa T; Hashimoto O; Seki H; Koyanagi K; Bessho T
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1667-70. PubMed ID: 19838025
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis, staging and therapy of gastric cancer].
Menges M
Z Gastroenterol; 2004 Aug; 42(8):767-73. PubMed ID: 15314730
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon cancer.
Fields AL; Keller A; Schwartzberg L; Bernard S; Kardinal C; Cohen A; Schulz J; Eisenberg P; Forster J; Wissel P
J Clin Oncol; 2009 Apr; 27(12):1941-7. PubMed ID: 19273708
[TBL] [Abstract][Full Text] [Related]
30. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
[TBL] [Abstract][Full Text] [Related]
31. [Adjuvant Chemotherapy for Gastric Cancer].
Takagi W; Terashima M
Gan To Kagaku Ryoho; 2016 Feb; 43(2):151-5. PubMed ID: 27067678
[TBL] [Abstract][Full Text] [Related]
32. [Administration of S-1 after gastrojejunostomy for unresectable gastric cancer with pyloric stenosis].
Nishikawa K; Iwase K; Fujii M; Matsuda C; Shimada K; Hirota M; Kimura T; Wada D; Nasu S; Tanaka Y
Gan To Kagaku Ryoho; 2009 Apr; 36(4):595-8. PubMed ID: 19381030
[TBL] [Abstract][Full Text] [Related]
33. [Long- and short-term survivors after chemotherapy among patients with advanced or recurrent gastric cancer in our hospital].
Yamamoto M; Matsuyama A; Kameyama T; Okamoto M; Okazaki J; Utsunomiya T; Tsutsui S; Ishida T
Gan To Kagaku Ryoho; 2008 Apr; 35(4):599-602. PubMed ID: 18408427
[TBL] [Abstract][Full Text] [Related]
34. [The future of loco-regional treatment for advanced gastric cancer].
Nagahama T; Ando M; Ganno H; Ami K; Fukuda A; Maruyama M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2012-4. PubMed ID: 19106507
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy for metastatic disease: review from JCOG trials.
Boku N;
Int J Clin Oncol; 2008 Jun; 13(3):196-200. PubMed ID: 18553227
[TBL] [Abstract][Full Text] [Related]
36. [Complete remission with FLEP chemotherapy for multiple liver metastasis from alpha-fetoprotein-producing gastric cancer--report of a case].
Takahashi T; Kochi M; Kanamori N; Kaiga T; Funada T; Fujii M; Takayama T
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1885-8. PubMed ID: 19920393
[TBL] [Abstract][Full Text] [Related]
37. Phase I study of the sequential administration of S-1 and cisplatin for metastatic gastric cancer.
Baba E; Fujishima H; Kusaba H; Esaki T; Ariyama H; Kato K; Tanaka R; Mitsugi K; Shibata Y; Harada M; Nakano S
Anticancer Res; 2009 May; 29(5):1727-32. PubMed ID: 19443394
[TBL] [Abstract][Full Text] [Related]
38. [Combination therapy with molecular targeting drugs for head and neck cancer].
Fujii M
Gan To Kagaku Ryoho; 2008 May; 35(5):740-4. PubMed ID: 18487910
[TBL] [Abstract][Full Text] [Related]
39. A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study).
Kodera Y; Ito S; Mochizuki Y; Kondo K; Koshikawa K; Suzuki N; Kojima H; Kojima T; Matsui T; Takase T; Tsuboi K; Fujiwara M; Nakao A;
Eur J Surg Oncol; 2009 Nov; 35(11):1158-63. PubMed ID: 19328643
[TBL] [Abstract][Full Text] [Related]
40. [Neoadjuvant Chemotherapy for Gastric Cancer].
Yoshikawa T; Sato T; Yamada T; Aoyama T; Ogata T; Cho H
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1157-1160. PubMed ID: 27760932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
